Tarsus Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.

About TARS

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. 

CEO
Bobak Azamian
CEOBobak Azamian
Employees
46
Employees46
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2017
Founded2017
Employees
46
Employees46

TARS Key Statistics

Market cap
459.33M
Market cap459.33M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
71.65K
Average volume71.65K
High today
$17.55
High today$17.55
Low today
$16.90
Low today$16.90
Open price
$16.90
Open price$16.90
Volume
48.50K
Volume48.50K
52 Week high
$31.00
52 Week high$31.00
52 Week low
$10.80
52 Week low$10.80

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

TARS Earnings

-$1.08
-$0.56
-$0.05
$0.47
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.